Is the higher level of serum IL-33 in patients with more aggressive lung cancer a vicious circle in which the surrounding tissues are stimulated to secrete IL-33 to promote the tumor growth, or is it a protection against a large number of tumor cells and their rapid proliferation that exerts a substantial anti-tumor effect. The gene discussed is IL33; the disease is lung cancer.